HUNTINGTON'S DISEASE

Clinical trials for HUNTINGTON'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new HUNTINGTON'S DISEASE trials appear

Sign up with your email to follow new studies for HUNTINGTON'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

Huntington's drug safety trial ends early: what we know

Disease control Terminated

This study looked at the long-term safety of an experimental drug called SAGE-718 for people with Huntington's disease. It was a phase 3 trial that planned to enroll 153 participants but was terminated early. The main goal was to track side effects and changes in vital signs, lab…

Matched conditions: HUNTINGTON'S DISEASE

Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

HUNTINGTON'S DISEASE

Get alerted when new HUNTINGTON'S DISEASE trials appear

Huntington's drug safety trial ends early: what we know